about
TNF-alpha inhibitors for ankylosing spondylitisSulfasalazine for ankylosing spondylitisMethotrexate for ankylosing spondylitisAdverse effects of biologics: a network meta-analysis and Cochrane overviewSafety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events.
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
TNF-alpha inhibitors for ankylosing spondylitis
@ast
TNF-alpha inhibitors for ankylosing spondylitis
@en
TNF-alpha inhibitors for ankylosing spondylitis
@en-gb
TNF-alpha inhibitors for ankylosing spondylitis
@nl
type
label
TNF-alpha inhibitors for ankylosing spondylitis
@ast
TNF-alpha inhibitors for ankylosing spondylitis
@en
TNF-alpha inhibitors for ankylosing spondylitis
@en-gb
TNF-alpha inhibitors for ankylosing spondylitis
@nl
prefLabel
TNF-alpha inhibitors for ankylosing spondylitis
@ast
TNF-alpha inhibitors for ankylosing spondylitis
@en
TNF-alpha inhibitors for ankylosing spondylitis
@en-gb
TNF-alpha inhibitors for ankylosing spondylitis
@nl
P2860
P1476
TNF-alpha inhibitors for ankylosing spondylitis
@en
P2093
Jil Beardmore
Lara Maxwell
P2860
P356
10.1002/14651858.CD005468
P577
2005-07-20T00:00:00Z